Home > Qtrly Results > DR REDDYS LABORATORIES

DR REDDYS LABORATORIES
Quarterly Results Analysis [Dec2025]

DR REDDYS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Top Undervalued Large Cap Stocks
COMMUNITY POLL
for DR REDDYS LABORATORIES
Please provide your vote to see the results

DR REDDYS LABORATORIES Quarterly Results

Consolidated Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
Audited
Jun2024
UnAudited
Mar2024
UnAudited
Revenues ₹8,753 Cr ₹8,828 Cr ₹8,572 Cr ₹8,528 Cr ₹8,381 Cr ₹8,038 Cr ₹7,696 Cr ₹7,114 Cr
Expenses ₹6,866 Cr ₹6,818 Cr ₹6,399 Cr ₹6,531 Cr ₹6,108 Cr ₹5,962 Cr ₹5,566 Cr ₹5,283 Cr
Operating Income ₹1,888 Cr ₹2,010 Cr ₹2,174 Cr ₹1,998 Cr ₹2,273 Cr ₹2,077 Cr ₹2,130 Cr ₹1,831 Cr
Other Income ₹269 Cr ₹324 Cr ₹290 Cr ₹522 Cr ₹150 Cr ₹308 Cr ₹187 Cr ₹198 Cr
Interest ₹94 Cr ₹91 Cr ₹83 Cr ₹66 Cr ₹82 Cr ₹76 Cr ₹60 Cr ₹59 Cr
Depreciation ₹521 Cr ₹505 Cr ₹476 Cr ₹455 Cr ₹471 Cr ₹397 Cr ₹381 Cr ₹368 Cr
Profit Before Tax ₹1,541 Cr ₹1,739 Cr ₹1,905 Cr ₹2,000 Cr ₹1,870 Cr ₹1,911 Cr ₹1,877 Cr ₹1,602 Cr
Profit After Tax ₹1,187 Cr ₹1,331 Cr ₹1,410 Cr ₹1,581 Cr ₹1,400 Cr ₹1,336 Cr ₹1,387 Cr ₹1,306 Cr
EPS ₹14.49 ₹16.13 ₹16.98 ₹19.10 ₹16.95 ₹15.06 ₹16.70 ₹15.71
Industry Peers & Returns1W1M1Y
DR REDDYS LABORATORIES 5.9% -3.7% -6.5%
SUN PHARMACEUTICAL INDUSTRIES -2.5% -7% -8%
DIVIS LABORATORIES -2.2% -7.2% 1.3%
CIPLA -5.5% -12.4% -5.1%
TORRENT PHARMACEUTICALS -4% 2.8% 27.1%
MANKIND PHARMA -0.7% -5.7% -20.6%
ZYDUS LIFESCIENCES 0.1% -5% -11.1%
LUPIN -1.9% 1.1% 1.6%
AUROBINDO PHARMA -2.9% -6.9% -4.8%

DR REDDYS LABORATORIES Quarterly Revenues

Revenues
Q-o-Q

-0.85 %

Y-o-Y

4.44 %

Quarters Revenues % Change
Dec2025 ₹8,753 Cr
-0.85
Sep2025 ₹8,828 Cr
2.99
Jun2025 ₹8,572 Cr
0.51
Mar2025 ₹8,528 Cr
1.76
Dec2024 ₹8,381 Cr
4.27
Sep2024 ₹8,038 Cr
4.45
Jun2024 ₹7,696 Cr
8.19
Mar2024 ₹7,114 Cr -

DR REDDYS LABORATORIES Quarterly Operating Profit

Operating Profit
Q-o-Q

-6.09 %

Y-o-Y

-16.96 %

Quarters Operating Profit % Change
Dec2025 ₹1,888 Cr
-6.09
Sep2025 ₹2,010 Cr
-7.53
Jun2025 ₹2,174 Cr
8.79
Mar2025 ₹1,998 Cr
-12.10
Dec2024 ₹2,273 Cr
9.46
Sep2024 ₹2,077 Cr
-2.51
Jun2024 ₹2,130 Cr
16.31
Mar2024 ₹1,831 Cr -
Operating Margins
Q-o-Q

-5.31 %

Y-o-Y

-20.50 %

Quarters Operating Margin% % Change
Dec2025 21.56%
-5.31
Sep2025 22.77%
-10.21
Jun2025 25.36%
8.24
Mar2025 23.43%
-13.61
Dec2024 27.12%
4.99
Sep2024 25.83%
-6.68
Jun2024 27.68%
7.54
Mar2024 25.74% -

DR REDDYS LABORATORIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-10.76 %

Y-o-Y

-15.19 %

Quarters Profit After Tax % Change
Dec2025 ₹1,187 Cr
-10.76
Sep2025 ₹1,331 Cr
-5.62
Jun2025 ₹1,410 Cr
-10.85
Mar2025 ₹1,581 Cr
12.94
Dec2024 ₹1,400 Cr
4.81
Sep2024 ₹1,336 Cr
-3.66
Jun2024 ₹1,387 Cr
6.14
Mar2024 ₹1,306 Cr -
PAT Margins
Q-o-Q

-10.02 %

Y-o-Y

-18.80 %

Quarters PAT Margin(%) % Change
Dec2025 13.56 %
-10.02
Sep2025 15.07 %
-8.39
Jun2025 16.45 %
-11.27
Mar2025 18.54 %
11.02
Dec2024 16.7 %
0.48
Sep2024 16.62 %
-7.77
Jun2024 18.02 %
-1.85
Mar2024 18.36 % -

DR REDDYS LABORATORIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-10.17 %

Y-o-Y

-14.51 %

Quarters EPS % Change
Dec2025 ₹14.49
-10.17
Sep2025 ₹16.13
-5.01
Jun2025 ₹16.98
-11.10
Mar2025 ₹19.1
12.68
Dec2024 ₹16.95
12.55
Sep2024 ₹15.06
-9.82
Jun2024 ₹16.7
6.30
Mar2024 ₹15.71 -

You may also like the below Video Courses